Latest observed contract and full preserved history
Saved source observation · CN4236466
Procurement of clinical input to support the MSAC application seeking to expand MBS items 73296 and 73297 to include germline testing for individuals with prostate cancer and cascade testing for biological relatives
A later observation replaced this one. The explorer’s totals use $28,875.00 from the latest observation, published 24 June 2026.
$19,250.00
Full reported contract value · AUD including applicable GST · 2026-03-20 to 2026-06-30
- Reporting agency
- Cancer Australia
- Reported supplier
- Medex Consulting Pty Ltd
- Reported ABN
- 85 292 764 684. Exemption as supplied: No.
- Category
- Health administration services
- Procurement method
- Open tender
- Original publication
- 2026-05-01 15:39:00 (ACT local time as supplied)
- Amendment publication
- Original notice; no amendment publication supplied
- Amendment reason
- Not supplied
- Agency reference
- F26/118
- Approach to market / standing offer
- ATM not supplied / SON4079631
- Consultancy
- No
- Confidentiality as reported
- Contract: No; outputs: No
- Source observation
- CN4236466 · Official weekly workbook ending 2026-05-02 · sheet “Contract Notice Export”, row 156.
Find this exact notice on AusTenderDownload attributed contract card
The original register may now show later corrections. The card and this observation keep the saved source date.